Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Dugo, Matteo"'
Autor:
Wang XQ; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Danenberg E; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Huang CS; National Taiwan University Hospital, College of Medicine, National Taiwan University and Taiwan Breast Cancer Consortium, Taipei, Taiwan., Egle D; Department of Gynecology, Brust Gesundheit Zentrum Tirol, Medical University Innsbruck, Innsbruck, Austria., Callari M; Fondazione Michelangelo, Milan, Italy., Bermejo B; Medical Oncology, Hospital Clínico Universitario de Valencia, Biomedical Research Institute INCLIVA, Valencia, Spain.; Medicine Department, Universidad de Valencia, Valencia, Spain.; Oncology Biomedical Research National Network (CIBERONC-ISCIII), Madrid, Spain., Dugo M; San Raffaele Hospital, Milan, Italy., Zamagni C; IRCCS Azienda Ospedaliero-universitaria di Bologna, Bologna, Italy., Thill M; Department of Gynecology and Gynecological Oncology, Agaplesion Markus Krankenhaus, Frankfurt am Main, Germany., Anton A; Hospital Universitario Miguel Servet, Zaragoza, Spain., Zambelli S; San Raffaele Hospital, Milan, Italy., Russo S; Department of Oncology, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy., Ciruelos EM; Hospital Universitario 12 de Octubre, Madrid, Spain., Greil R; 3rd Medical Department, Paracelsus Medical University Salzburg, Salzburg, Austria.; Salzburg Cancer Research Institute-CCCIT, Salzburg, Austria.; Cancer Cluster Salzburg, Salzburg, Austria., Győrffy B; Department of Bioinformatics, Semmelweis University, Budapest, Hungary.; Cancer Biomarker Research Group, Research Centre for Natural Sciences, Institute of Enzymology, Budapest, Hungary., Semiglazov V; NN Petrov Research Institute of Oncology, St. Petersburg, Russia., Colleoni M; IEO, Istituto Europeo di Oncologia, IRCCS, Milan, Italy., Kelly CM; Mater Private Hospital, Dublin and Cancer Trials Ireland Breast Group, Dublin, Ireland., Mariani G; Fondazione IRCSS - Istituto Nazionale Tumori, Milan, Italy., Del Mastro L; IRCCS Ospedale Policlinico San Martino, UO Clinica di Oncologia Medica, Genoa, Italy.; Dipartimento di Medicina Interna e Specialità Mediche (Di.M.I.), Università di Genova, Genoa, Italy., Biasi O; IEO, Istituto Europeo di Oncologia, IRCCS, Milan, Italy., Seitz RS; Oncocyte Corporation, Irvine, CA, USA., Valagussa P; Fondazione Michelangelo, Milan, Italy., Viale G; IEO, Istituto Europeo di Oncologia, IRCCS, Milan, Italy.; University of Milan, Milan, Italy., Gianni L; Fondazione Michelangelo, Milan, Italy., Bianchini G; Fondazione Michelangelo, Milan, Italy. bianchini.giampaolo@hsr.it.; San Raffaele Hospital, Milan, Italy. bianchini.giampaolo@hsr.it., Ali HR; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK. raza.ali@cruk.cam.ac.uk.; Department of Histopathology, Addenbrookes Hospital, Cambridge, UK. raza.ali@cruk.cam.ac.uk.
Publikováno v:
Nature [Nature] 2023 Sep; Vol. 621 (7980), pp. 868-876. Date of Electronic Publication: 2023 Sep 06.
Autor:
Huber V; Unit of Immunotherapy of Human Tumors, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori di Milano, Milan, Italy., Vallacchi V; Unit of Immunotherapy of Human Tumors, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori di Milano, Milan, Italy., Fleming V; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, and Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Heidelberg, Germany., Hu X; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, and Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Heidelberg, Germany., Cova A; Unit of Immunotherapy of Human Tumors, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori di Milano, Milan, Italy., Dugo M; Platform of Integrated Biology., Shahaj E; Unit of Immunotherapy of Human Tumors, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori di Milano, Milan, Italy., Sulsenti R; Unit of Immunotherapy of Human Tumors, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori di Milano, Milan, Italy., Vergani E; Unit of Immunotherapy of Human Tumors, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori di Milano, Milan, Italy., Filipazzi P; Unit of Immunotherapy of Human Tumors, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori di Milano, Milan, Italy., De Laurentiis A; Unit of Immunotherapy of Human Tumors, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori di Milano, Milan, Italy., Lalli L; Unit of Immunotherapy of Human Tumors, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori di Milano, Milan, Italy., Di Guardo L; Medical Oncology Unit 1, and., Patuzzo R; Melanoma and Sarcoma Surgery Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Vergani B; Microscopy and Image Analysis Consortium, Università degli Studi di Milano-Bicocca, Monza, Italy., Casiraghi E; Department of Computer Science 'Giovanni Degli Antoni,' Università degli Studi di Milano, Milan, Italy., Cossa M; Molecular Pathology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Gualeni A; Molecular Pathology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Bollati V; EPIGET-Epidemiology, Epigenetics and Toxicology Lab, Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy., Arienti F; Immunohematology and Transfusion Medicine, and., De Braud F; Medical Oncology Unit 1, and., Mariani L; Medical Statistics, Biometry and Bioinformatics, Unit of Clinical Epidemiology and Trial Organization, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Villa A; Microscopy and Image Analysis Consortium, Università degli Studi di Milano-Bicocca, Monza, Italy., Altevogt P; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, and Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Heidelberg, Germany., Umansky V; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, and Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Heidelberg, Germany., Rodolfo M; Unit of Immunotherapy of Human Tumors, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori di Milano, Milan, Italy., Rivoltini L; Unit of Immunotherapy of Human Tumors, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2018 Dec 03; Vol. 128 (12), pp. 5505-5516. Date of Electronic Publication: 2018 Nov 05.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Licata, Luca, Mariani, Marco, Rossari, Federico, Viale, Giulia, Notini, Giulia, Naldini, Matteo Maria, Bosi, Carlo, Piras, Marta, Dugo, Matteo, Bianchini, Giampaolo
Publikováno v:
Breast; Jun2023, Vol. 69, p330-341, 12p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Rinchai, Darawan, Verzoni, Elena, Huber, Veronica, Cova, Agata, Squarcina, Paola, De Cecco, Loris, Braud, Filippo, Ratta, Raffaele, Dugo, Matteo, Lalli, Luca, Vallacchi, Viviana, Rodolfo, Monica, Roelands, Jessica, Castelli, Chiara, Chaussabel, Damien, Procopio, Giuseppe, Bedognetti, Davide, Rivoltini, Licia
Publikováno v:
Clinical and Translational Medicine
Clinical and Translational Medicine, Vol 11, Iss 6, Pp n/a-n/a (2021)
Clinical and Translational Medicine, Vol 11, Iss 6, Pp n/a-n/a (2021)
Background The combination of immune checkpoint blockade (ICB) with standard therapies is becoming a common approach for overcoming resistance to cancer immunotherapy in most human malignancies including metastatic renal cell carcinoma (mRCC). In thi